Skip to main content
Premium Trial:

Request an Annual Quote

Number Crunch Finding Funding


Michigan announced the recipients of $30 million from the Michigan Life Sciences Corridor — projects specifically involving genomics and proteomics garnered a good chunk of that. The news came on the heels of the state’s earlier announcement that it had slashed $12.5 million out of the group’s $45 million annual budget for 2003 and would lower 2004 funding even more, to $20 million.

Of the awards announced, GT rounded up those that appear most related to genomics, bioinformatics, and proteomics below.

Awardee Project Title Funding

Richard Everson,
Wayne State University

Streamlining genomics for personalized medicine


Phil Andrews,
University of Michigan

Michigan Proteome Consortium


Jack Preiss,
Michigan State University

Michigan Center for Structural Biology


Tatiana Nikolskaya,

Platform technology for in silico reconstruction of disease states


James Tiedje,
Michigan State University

GeneScreen: A low-cost and high-density DNA biochip for detecting up to 30,000 microorganisms


Mark Hughes,
Wayne State University

Genomics Facility for the Life Sciences Corridor


Mark Kielb,
DNA Software

Commercializing software for microarray and advanced PCR assay design


The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.